Intergalactic Therapeutics is developing non-viral gene therapies to treat or cure diseases. Intergalactic is creating therapies using their versatile synthetic non-viral cargo platform, C3DNA to identify customized approaches to therapeutic delivery. C3DNA is a covalently closed and circular DNA construct that can be taken up by cells and expressed without insertion into the host genome. C3DNA is fully synthetic, lacking bacterial or viral sequences, and can therefore avoid triggering immune reactions and allow re-dosing. Intergalactic’s cell-free manufacturing process enables rapid, scalable therapy production. Intergalactic is building a diverse portfolio for eye diseases, cancers and respiratory illnesses.

<p>Intergalactic Therapeutics is developing non-viral gene therapies to treat or cure diseases. Intergalactic is creating therapies using their versatile synthetic non-viral cargo platform, C3DNA to identify customized approaches to therapeutic delivery. C3DNA is a covalently closed and circular DNA construct that can be taken up by cells and expressed without insertion into the host genome. C3DNA is fully synthetic, lacking bacterial or viral sequences, and can therefore avoid triggering immune reactions and allow re-dosing. Intergalactic’s cell-free manufacturing process enables rapid, scalable therapy production. Intergalactic is building a diverse portfolio for eye diseases, cancers and respiratory illnesses.</p>


Intergalactic Therapeutics

Intergalactic Therapeutics

Company info:

About company:

Jobs: